401 related articles for article (PubMed ID: 15797513)
1. Cellular ligands of activating NK receptors.
Bottino C; Castriconi R; Moretta L; Moretta A
Trends Immunol; 2005 Apr; 26(4):221-6. PubMed ID: 15797513
[TBL] [Abstract][Full Text] [Related]
2. NK cell activating ligands on human malignant cells: molecular and functional defects and potential clinical relevance.
Chang CC; Ferrone S
Semin Cancer Biol; 2006 Oct; 16(5):383-92. PubMed ID: 16931041
[TBL] [Abstract][Full Text] [Related]
3. Different checkpoints in human NK-cell activation.
Moretta L; Bottino C; Pende D; Vitale M; Mingari MC; Moretta A
Trends Immunol; 2004 Dec; 25(12):670-6. PubMed ID: 15530838
[TBL] [Abstract][Full Text] [Related]
4. Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate.
Armeanu S; Bitzer M; Lauer UM; Venturelli S; Pathil A; Krusch M; Kaiser S; Jobst J; Smirnow I; Wagner A; Steinle A; Salih HR
Cancer Res; 2005 Jul; 65(14):6321-9. PubMed ID: 16024634
[TBL] [Abstract][Full Text] [Related]
5. Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS.
Iannello A; Debbeche O; Samarani S; Ahmad A
J Leukoc Biol; 2008 Jul; 84(1):1-26. PubMed ID: 18388298
[TBL] [Abstract][Full Text] [Related]
6. Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression.
Song H; Kim J; Cosman D; Choi I
Cell Immunol; 2006 Jan; 239(1):22-30. PubMed ID: 16630603
[TBL] [Abstract][Full Text] [Related]
7. NKG2C is a major triggering receptor involved in the V[delta]1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells.
Fausther-Bovendo H; Wauquier N; Cherfils-Vicini J; Cremer I; Debré P; Vieillard V
AIDS; 2008 Jan; 22(2):217-26. PubMed ID: 18097224
[TBL] [Abstract][Full Text] [Related]
8. Increased frequency of human leukocyte antigen-E inhibitory receptor CD94/NKG2A-expressing peritoneal natural killer cells in patients with endometriosis.
Galandrini R; Porpora MG; Stoppacciaro A; Micucci F; Capuano C; Tassi I; Di Felice A; Benedetti-Panici P; Santoni A
Fertil Steril; 2008 May; 89(5 Suppl):1490-6. PubMed ID: 17706207
[TBL] [Abstract][Full Text] [Related]
9. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].
Guo KY; Mei JZ; Yao KT
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963
[TBL] [Abstract][Full Text] [Related]
10. Structural immunology and crystallography help immunologists see the immune system in action: how T and NK cells touch their ligands.
Chen Y; Shi Y; Cheng H; An YQ; Gao GF
IUBMB Life; 2009 Jun; 61(6):579-90. PubMed ID: 19472182
[TBL] [Abstract][Full Text] [Related]
11. Unravelling natural killer cell function: triggering and inhibitory human NK receptors.
Moretta L; Moretta A
EMBO J; 2004 Jan; 23(2):255-9. PubMed ID: 14685277
[TBL] [Abstract][Full Text] [Related]
12. Human natural killer cells: Molecular mechanisms controlling NK cell activation and tumor cell lysis.
Moretta L; Bottino C; Pende D; Vitale M; Mingari MC; Moretta A
Immunol Lett; 2005 Aug; 100(1):7-13. PubMed ID: 16109445
[TBL] [Abstract][Full Text] [Related]
13. Surface NK receptors and their ligands on tumor cells.
Moretta L; Bottino C; Pende D; Castriconi R; Mingari MC; Moretta A
Semin Immunol; 2006 Jun; 18(3):151-8. PubMed ID: 16730454
[TBL] [Abstract][Full Text] [Related]
14. NK cell receptors as tools in cancer immunotherapy.
Sentman CL; Barber MA; Barber A; Zhang T
Adv Cancer Res; 2006; 95():249-92. PubMed ID: 16860660
[TBL] [Abstract][Full Text] [Related]
15. NKG2D and natural cytotoxicity receptors are involved in natural killer cell interaction with self-antigen presenting cells and stromal cells.
Poggi A; Prevosto C; Zancolli M; Canevali P; Musso A; Zocchi MR
Ann N Y Acad Sci; 2007 Aug; 1109():47-57. PubMed ID: 17785290
[TBL] [Abstract][Full Text] [Related]
16. Imbalance of NKG2D and its inhibitory counterparts: how does tumor escape from innate immunity?
Zhang C; Zhang J; Wei H; Tian Z
Int Immunopharmacol; 2005 Jul; 5(7-8):1099-111. PubMed ID: 15914316
[TBL] [Abstract][Full Text] [Related]
17. Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients.
Maat W; van der Slik AR; Verhoeven DH; Alizadeh BZ; Ly LV; Verduijn W; Luyten GP; Mulder A; van Hall T; Koning F; Jager MJ; van Bergen J
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2888-95. PubMed ID: 19234348
[TBL] [Abstract][Full Text] [Related]
18. PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis.
Pende D; Bottino C; Castriconi R; Cantoni C; Marcenaro S; Rivera P; Spaggiari GM; Dondero A; Carnemolla B; Reymond N; Mingari MC; Lopez M; Moretta L; Moretta A
Mol Immunol; 2005 Feb; 42(4):463-9. PubMed ID: 15607800
[TBL] [Abstract][Full Text] [Related]
19. Do NK-cell receptors and alloreactivity affect solid organ transplantation?
Vilches C; Parham P
Transpl Immunol; 2006 Dec; 17(1):27-30. PubMed ID: 17157210
[TBL] [Abstract][Full Text] [Related]
20. Transgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
Lilienfeld BG; Crew MD; Forte P; Baumann BC; Seebach JD
Xenotransplantation; 2007 Mar; 14(2):126-34. PubMed ID: 17381687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
